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Abstract 
Home manufactured methamphetamine known as ‘Pervitin’ has historically dominated the 
drug market in the Czech and Slovak Republics.  Seizures and surveillance data indicate 
some displacement of ‘Pervitin’ across Europe to areas of low reported prevalence (Nordic 
countries, Germany, Cyprus, Greece and Portugal). We present the first single case study of 
clandestine production of ‘Pervitin’ to Ireland, a country with low reporting history of 
methamphetamine. Content analysis yielded three descriptive themes; ‘Pervitin’ use, 
Decisions to Use and Effects; Legality and Hazards; and ‘Clandestine Manufacture.’ The 
study yielded unique insight into migration of this culturally specific drug, and how 
continued cultural contexts for use and ‘cooking’ remain intact when residing in the host 
country. Given its unique cultural nature and national characteristics, continued migration of 
Eastern European citizens across Europe, diffusion of clandestine production warrants 
continued surveillance. Appropriate service responses require culturally appropriate 
information and outreach services to Eastern European service users.  
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Introduction  
Amphetamine-type stimulants (ATS) are controlled substances, with a number regulated for 
treatment of disorders such as attention deficit hyperactivity disorder (ADHD), narcolepsy, 
and depression (Berman et al. 2009).  The use and clandestine manufacture of ATS such as 
amphetamine, d-amphetamine, methamphetamine, methylphenidate, 3,4- 
methylenedioxymethamphetamine (MDMA), cathinone, methcathinone, pseudoephedrine, 
fenetylline, and ephedrine is reported worldwide, and in some countries surpasses that of 
cocaine or opiates (Mackey et al. 2014; Nikolaou et al. 2014; Tait et al. 2012; UNODC 
2015). The UNODC (2015) underscores the rapidly expanding market of ATS globally, with 
increasing seizures of methamphetamine from 34 tons in 2009 to 88 tons in 2013. 
Methamphetamine has a high dependence liability (Murray 1998; Wolkoff 1997). In 2013, 
methamphetamine treatment accounted for the majority of treatment cases in many countries 
(UNODC 2015).  
 
Methamphetamine is a significant problem in East and South-East Asia (‘Yaba’; ‘Ice’; 
‘Shabu’) (Kulsudjarit 2004), North America (‘Crystal Meth’, ‘Crank’) and Australia (‘Ice’) 
(UNODC 2015) and more recently indicated as new trend in Europe with regard to increasing 
availability of crystalline methamphetamine in European countries such as Germany, Greece 
(‘Sisa’) and Turkey where use of methamphetamine has not been reported before (EMCDDA 
2014a,b). Methamphetamine has historically dominated the drug market in the Czech and 
Slovak Republics (‘Pervitin’, ‘Vint’, ‘Shirka’ (Csete 2012; Grund et al. 2009; Zábranský 
2007). With the exception of the Czech and Slovak Republic, a low prevalence of 
methamphetamine use was previously reported in most European member states (Bruggisser 
et al. 2010; Csemy et al. 2002; Griffith et al. 2008; Krakowiak et al. 2010; Maxwell and 
Rutkowski 2008; McKetin et al. 2008; Schifano et al. 2010; Sudakin and Power 2009; 
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Verschraagen et al. 2007). Rising seizures are reported in the Baltics and Eastern Europe 
(Belarus, Latvia, Lithuania and the Republic of Moldova), and with diffusion of use to further 
afield in the Nordic countries, Germany, Cyprus, Greece and Portugal (Degenhardt et al. 
2010; EMCDDA 2014a,b; Griffiths et al. 2008; Pietsch et al. 2013; UNODC 2015). 
 
EMCDDA reporting in recent times has underscored the unique cultural nature and national 
characteristics of methamphetamine use in comparison to other illicit drug use across Europe. 
Popularity and appetite for methamphetamine in the Czech Republic originated from user 
ingenuity once detached from imported drugs by the Iron Curtain (Kulish 2007). However, 
regional trends in methamphetamine markets have been observed in the 2013 EMCDDA 
Trendspotter study, with distinct use patterns, production, and marketing of the drug 
(EMCDDA 2014a,b). Factors stimulating the diffusion of methamphetamine from the Czech 
Republic into Europe whilst not significant and impeded by the presence of other stimulant 
drugs (cocaine, amphetamine and MDMA) (Griffiths et al. 2008) appear to centre on its 
appeal as alternative to cocaine, along with the migrant flow of Czech workers within the EU 
domain (Kulish 2007).  More recently, the supply diffusion of methamphetamine observed 
across Europe has indicated the potential replacement of amphetamine in the stimulant 
markets, from marginalised problematic drug user populations who smoke and inject, into 
that of socially integrated recreational users who sniff or inject, and the displacement of 
production itself (EMCDDA-Europol 2009). In the UK, methamphetamine use is appearing 
among high risk more affluent groups of drug users such as men who have sex with men, and 
engage in ‘chemsex’ activity (MSM) (Bourne et al. 2015; EMCDDA 2014a;.  
 
In Central and Eastern Europe, the tradition of home manufacture of ‘Pervitin’ is culturally 
and historically grounded (Griffiths et al. 2008; Grund and Merkinaite 2009; Grund et al. 
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2009; Mravčík et al. 2008; Van Hout 2014; Zábranský 2007).  Production in the Czech 
Republic generally takes place in ‘kitchen labs’ for own personal use (Zábranský 2007). 
Small groups of ‘cooks’ and their helpers characterised by close personal relationships in 
home production and self supply dominate the system (Miovský 2007). More recently, larger 
(mid to large scale) methamphetamine production sites were detected outside of the Czech 
Republic in the Slovac Republic, Belgium, Netherlands, Poland, Portugal, Ireland, United 
Kingdom and Germany (EMCDDA-Europol 2009). It can be easily produced from pre-cursor 
substances pseudoephedrine and ephedrine found as ingredients in common ‘over the 
counter’ cold remedies for symptomatic relief of colds, flu and other similar conditions (Topp 
et al. 2002). According to EMCDDA-Europol (2009) five known methamphetamine 
production methods exist in Europe, with the three most common known as lithium-
ammonia, hypophosphorous acid/iodine and hydriodic acid/red phosphorus. All three are 
dependent on availability of pre-cursors, the expertises of ‘cooks’ and are relatively simple, 
one-step reactions of ephedrine or pseudo-ephedrine in cold remedies sold without 
prescription in pharmacies, using stainless steel or glass equipment. The generation of 
hydrogen gas, toxic fumes, and corrosive and flammable hazards are evident (Europol 
2007a,b,c). Media reporting in 2015 highlights concern around the profitability of ‘Pervitin’ 
manufacture with increasing flow of medicines from Poland to the Czech Republic for home 
manufacture of methamphetamine, involvement of Vietnamese in the production cycle and 
trafficking into Germany (Bavaria and Saxony) (Prague Daily Monitor 2015).  
 
Despite the low prevalence of methamphetamine use previously reported in most European 
Member States, in 2016, media reporting of ‘Pervitin’ in Ireland, a country with very low 
prevalence of methamphetamine use, increased.  In 2015, the Health Service Executive 
issued a number of alerts regarding pharmacovigilance in dealing with Eastern European 
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customer requests for multiple packs of over the counter medicines containing 
pseudoephedrine (for example Sudafed ®), and often in large groups. The Irish Health 
Products Regulatory Authority had considered reducing the size of medicine packs in a bid to 
counter the manufacture of methamphetamine (Logan 2012), and in 2015, the Pharmaceutical 
Society of Ireland (PSI) issued a warning to pharmacists in relation to sales of 
pseudoephedrine-containing products. Harm reduction services indicated concerns around 
claims of methamphetamine sold by Nigerian gangs in Dublin, as found to contain synthetic 
psycho-active methylenedioxypyrovalerone (MDPV) and pyrrolidinopentiophenone (PVP) 
some of the newer novel psychoactive substances (NPS). We present here the first known 
single case study of migrated ‘Pervitin’ home manufacture (hereafter referred to as ‘cooking’) 
into Ireland.  
 
Method 
Ethical approval for the study was granted at Waterford Institute of Technology, Republic of 
Ireland in October 2015. The study aimed to explore migrancy and the cultural choices and 
decision making for Eastern European drug users resident in Ireland to use and make 
‘Pervitin’.   We utilised the Privileged Access Interviewing approach which has been 
successfully utilised in accessing hard to reach populations, particularly PWID where 
outsides are viewed with mistrust and suspicion, and which achieves rich data retrieval in 
short timeframes (March et al. 2006; Taylor and Kearney 2005; Van Hout and Bingham 
2012). The case was recruited from a known existing network of Eastern European accessing 
harm reduction services in Ireland. Despite several attempts to recruit members from within 
the ‘cooking’ group in terms of the key actors, this was not successful due to the closed and 
hidden nature of the network itself.  Hence we report here on the single case observations of 
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the processes and use patterns of ‘Pervitin’ within a closed Eastern European network in 
Dublin, Ireland.  
 
The single case was interviewed twice at two time points six months apart following 
informed consent, and described her observations and experiences in relation to a known 
group of Czech and Slovakian ‘Pervitin’ cookers and users in Dublin, Ireland. Interview 
themes centred on cultural preferences to bring ‘Pervitin’ to Ireland, migration of ‘Pervitin’ 
specific cooking and using practices into Ireland, dynamics, meanings and settings around 
‘cooking’, interplay with ‘outsiders’ and the existing Irish street drug market, sourcing of pre-
cursor ingredients and clandestine home cooking practices, accidents and risks of exposure. 
Interviews were conducted in English, the case’s second language, were in depth and lasted 
90 minutes on both occasions. She did not receive compensation. We asked the case to 
describe and reflect on her experiences with ‘Pervitin’, and observations of ‘Pervitin’ cooking 
over the course of a year. Memos and observational and analytical field notes were included 
in the analysis notes (Caeili 2001). Narratives were analysed by delineating the data into units 
of meaning and clustering into emergent thematic patterns within the holistic context 
(Moustakas 1994). ‘Outliers’ were analysed by the team under conditions by which outliers 
could be interpreted (De Castro 2003). 
 
Results: 
Findings are illustrative of the use and production of ‘Pervitin’ in Ireland among Eastern 
European migrants. Three central descriptive themes emerged from the data, namely; 
‘Pervitin’ use, Decisions to Use and Effects; Legality and Hazards; and ‘Clandestine 
Manufacture.’ 
 
7 
 
Pervitin Use, Decisions to Use and Effects  
‘Pervitin’ pricing, dosing properties, and effects of ‘Pervitin’ use were described by the case. 
Route of administration was reported as being primarily inhalation by others or insufflation 
which was the preferred route by the case herself. Injecting use of ‘Pervitin’ was not reported. 
“I snort it, always. Other people that I know they’d smoke it. That wouldn’t be for 
me, I dunno I find the addiction is stronger there if you smoke it never mind 
injecting or anything like that, that’s not me. Snorting, fine you can control.” 
Potency of ‘Pervitin’ was said to be very strong and as a result dosing in small quantities was 
described by our case, and advocated within user networks of Czech and Slovak immigrants. 
Moderated controlled use appeared normalised within these networks.  
“The Piko is so strong so strong, you do literally, say you have a straw, the 
opening of a straw is what I do and that would get me through the day, easily. 
And the longer you don’t take it, the longer it would work then when you go back 
on it.” 
She reported no compulsion to re-dose throughout the day if using as “mama’s little helper” 
or at night when socialising with friends. 
“If I do take more, it’s because I want to, not because I feel the need” 
“Mama’s little helper, because it’s just to get you through the day kind of a thing, 
you know.” 
Cost was the only reported negative outcome of ‘Pervitin’ use.  
“€150 a gram. Quite expensive and you never know what you’re getting.” 
Poor quality of Illicit substances in Ireland such as cocaine was reported as a motive to 
purchase and consume home made ‘Pervitin’  
“The Irish stuff isn’t good, like if somebody says ‘oh I have this cocaine’, for me 
I’d say ‘no’ because I know that the Piko [‘Pervitin’]  is always good” 
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Methamphetamine type effects such as euphoria, lack of sleep or appetite, energy, increased 
well-being and sociability were described. Chronic outcomes centred on weight loss.  
“You don’t need to drink, you can drink if you want – you can drink alcohol like 
crazy but you’re not getting drunk, and you are talking non-stop, and all of a 
sudden it’s morning you know.” 
While the case described herself as “I don’t think I am a person who has tendencies to 
addiction” as she did refer to development of tolerance and withdrawals over time.  
“When it’s gone, I notice my behaviour changes a little bit. I don’t feel  that  I am 
looking for  more, but only by reading up on it then, it’s like “Jesus yeah I do get 
a little bit more short  tempered” or  a bit more aggressive.” 
 
Clandestine Manufacture  
Cooking of ‘Pervitin’ by migrated groups of Czech and Slovak individuals in Ireland was 
described, and appeared central to their cultural networks in Ireland.  
“Like it’s not coming from, imported in another country, it’s actually cooked in 
Ireland. I really thought it was coming from Czech Republic, but they are actually 
Czech and Slovakian living in Dublin’ 
This occurred in private homes with a ‘cook’ as experienced clandestine chemist, and with 
peer users assisting.  Other factors implicating decisions to purchase and use home-made 
‘Pervitin’ centred on presence of different ‘cooks’ using different processes and ingredients, 
and the wide variability of quality and consistency of effect. 
“It’s like Breaking Bad style, like they have it in the kitchen and then they’re 
cooking it up, so it can be hit and miss. You never know because it’s different 
people cooking it.” 
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The ingredients (for example over the counter cold medications containing pseudoephedrine) 
required to make ‘Pervitin’ in the home are purchased in pharmacies in Ireland, as reported 
by the case.  
“they are definitely buying the ingredients in Ireland” 
The case reported intentions of the cooks and users of ‘Pervitin’ to filter into the Irish drugs 
market as market competitor of existing street stimulants.  
 “the guy whoever cooks it in Dublin, they are hoping to get into the Irish market 
because the Irish are so - once you have those people or the young twenty year 
old like, once you get them hooked, I could see dangers there” 
 
Legality and Hazards 
The case described how she did not worry about the legal consequences of possessing 
‘Pervitin’. This perception of security was grounded in her storage of the drug in her 
fridge at home. Street use and street dealing was not referred to, and ‘Pervitin’ appeared 
to be somewhat normalised by virtue of its manufacture and use within the home. 
“The cops - no. I don’t carry it around with me either it’s in my fridge you 
know.”  
The case was aware of hazards in safe storage in relation to paediatric consumption and 
accidental overdose. Her primary fear was of social services deeming her dependent on 
drugs and unable to care for her child. 
“I am a single mum it would worry me a bit if whoever would say to the social 
and they would come out here and have a look, That would be my worry as a 
mother, a fear, that’s not really the law.’ 
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Discussion 
This study is one of the first efforts in the literature to address and examine the migration of 
‘Pervitin’ use and production to Ireland. Since no data have been available in Ireland so far, 
the use of this method as a first approach was justifiable. The study yielded unique insight 
into migration of this culturally specific drug, ‘Pervitin’ and how continued cultural contexts 
for use and ‘cooking’ remain intact when residing in the host country. Whilst we recognise 
the confines of this approach (Baxter and Jack 2008; Yin 2003), the exploration of this recent 
novel and culturally specific drug practice within eastern European cultural networks in 
Ireland is unique and merited. The study yielded rich and innovative insights into the 
migration of the culturally specific drug, ‘Pervitin’ with Czech citizens and how continued 
cultural contexts for use and manufacture remain intact when residing in the host country. 
The diffusion of methamphetamine in Europe, whilst culturally bound to the Czech and 
Slovak Republics, is to date impeded by the strong market of traditional stimulant drugs 
(cocaine, amphetamine, MDMA) (Griffiths et al. 2008) and NPS. Griffiths et al. (2008) 
however underscore the need to monitor the spread of methamphetamines popularity in 
Europe as influenced by drug market factors, ‘leakage’ from areas of high prevalence, travel 
of young Europeans into areas of high prevalence, and user perceptions around desirability 
and cost benefit when compared to other stimulants. Despite anecdotal reporting of NPS 
branded as methamphetamine sold on Irish streets, this form of drug use and production 
appeared insular and confined by cultural boundaries.   
 
Potency and cost were both high, and appeared to further solidify the exclusivity of this drug 
within these close networks of Czech migrants. Similar to extant literature in their originating 
country, ‘Pervitin’ is prepared by small, close knit groups of users, in this instance not 
injecting drug users, and revolving around the ‘cook’ (Grund 2005; Grund et al. 2009; 
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Miovský 2007; Van Hout 2014;). Home-made labs represent atypical risk environments 
(Rhodes, 2009; Miovský et al. 2015) with synthesis taking place in primitive settings, with 
substandard equipment and ingredients (Grund et al. 2009). Equally concerning are the risks 
of contamination, absence of correct protocols and purification methods, and highly toxic 
reactants (Alves et al. 2015; Caldicott et al. 2005; Grund et al. 2013; Martyny et al. 2007; 
Ning Chiu et al. 2011;). Hazards in production centre on the potential for life threatening 
injuries in places serving simultaneously as lab and home due to fires and explosions, and the 
exposure to toxic by-products of bystanders and children (Linberry and Bostwick 2006). If 
children are present, concerns are evident with regard to environmental hazards and 
paediatric consumption (Grant 2007; Mecham and Melini 2002;).  
 
Acute effects reported were similar to those reported in the literature and centred on 
disinhibition, euphoria, decreased need for food and sleep, increased sociability, wellbeing 
and energy, and with a high probability of dependence (Sheridan et al. 2006). Adverse health 
consequences centre on the emergent, acute, subacute, and chronic effects on cardiac, 
neurologic, pulmonary, dental, and other systems (Linberry and Bostwick 2006).  Given the 
range of health related harms associated with problematic use and the potential progression 
toward injecting use and risk of blood borne virus transmission (Hepatitis C/ HIV), public 
health and harm reduction surveillance is warranted.  
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Conclusion   
Given its unique cultural nature and national characteristics, continued migration of Eastern 
European citizens across Europe, diffusion of clandestine production of ‘Pervitin’ warrants 
continued surveillance. In Ireland, given the recent regulatory concerns, and harm reduction 
service reporting around this issue, continued research is warranted in order to inform 
appropriate service responses. Such service responses require culturally appropriate 
information and outreach services to Eastern European service users. Equally warranted is the 
specialised training of critical care staff in meth lab injuries (Santos et al. 2005). 
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